Dr. Reddy’s Laboratories has introduced Methylphenidate Hydrochloride extended-release tablets, indicated for the treatment of attention deficit hyperactivity disorder, in the U.S. market.
The tablets are therapeutic-equivalent generic version of Concerta (methylphenidate hydrochloride) extended-release tablets. Concerta is a trademark owned or licensed by Janssen Pharmaceuticals Inc., the company said.
The Concerta brand and generic market had U.S. sales of approximately $1.159 billion MAT for the most recent 12 months ended in June 2020, Dr. Reddy’s said.
ADVERTISEMENT
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.
This is your last free article.